AGAP5
geneOn this page
Also known as Em:AC073389.1
Summary
AGAP5 (ArfGAP with GTPase domain, ankyrin repeat and PH domain 5, HGNC:23467) is a protein-coding gene on chromosome 10q22.2, encoding Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5 (A6NIR3). Putative GTPase-activating protein. It is a selective cancer dependency (DepMap: 80.6% of cell lines).
Predicted to enable GTPase activator activity and GTPase activity.
Source: NCBI Gene 729092 — RefSeq curated summary.
At a glance
- GWAS associations: 6
- Clinical variants (ClinVar): 127 total
- Cancer dependency (DepMap): dependent in 80.6% of screened cell lines
- MANE Select transcript:
NM_001144000
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:23467 |
| Approved symbol | AGAP5 |
| Name | ArfGAP with GTPase domain, ankyrin repeat and PH domain 5 |
| Location | 10q22.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Aliases | Em:AC073389.1 |
| Ensembl gene | ENSG00000172650 |
| Ensembl biotype | protein_coding |
| OMIM | 621156 |
| Entrez | 729092 |
Gene structure
Transcript identifiers
Ensembl transcripts: 3 — 2 protein_coding, 1 nonsense_mediated_decay
ENST00000374094, ENST00000443782, ENST00000607663
RefSeq mRNA: 1 — MANE Select: NM_001144000
NM_001144000
CCDS: CCDS44439
Canonical transcript exons
ENST00000374094 — 8 exons
| Exon | Start | End |
|---|---|---|
| ENSE00001663819 | 73674295 | 73676074 |
| ENSE00003493653 | 73697095 | 73697163 |
| ENSE00003536518 | 73676719 | 73676770 |
| ENSE00003612965 | 73692043 | 73692077 |
| ENSE00003645100 | 73680071 | 73680106 |
| ENSE00003650132 | 73682694 | 73682794 |
| ENSE00003688909 | 73694736 | 73694804 |
| ENSE00003737171 | 73697533 | 73698109 |
Expression profiles
Bgee: expression breadth ubiquitous, 134 present calls, max score 87.62.
Top tissues by expression
134 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| body of pancreas | UBERON:0001150 | 87.62 | gold quality |
| right testis | UBERON:0004534 | 86.66 | gold quality |
| male germ line stem cell (sensu Vertebrata) in testis | CL:0000089 ∩ UBERON:0000473 | 86.58 | gold quality |
| left testis | UBERON:0004533 | 86.34 | gold quality |
| testis | UBERON:0000473 | 85.74 | gold quality |
| right uterine tube | UBERON:0001302 | 85.14 | gold quality |
| apex of heart | UBERON:0002098 | 83.80 | gold quality |
| right lobe of liver | UBERON:0001114 | 83.19 | gold quality |
| endometrium | UBERON:0001295 | 83.06 | gold quality |
| right ovary | UBERON:0002118 | 82.95 | gold quality |
| skin of leg | UBERON:0001511 | 82.42 | gold quality |
| pituitary gland | UBERON:0000007 | 82.33 | gold quality |
| small intestine Peyer’s patch | UBERON:0003454 | 82.33 | gold quality |
| left ovary | UBERON:0002119 | 82.07 | gold quality |
| zone of skin | UBERON:0000014 | 82.06 | gold quality |
| fundus of stomach | UBERON:0001160 | 81.98 | gold quality |
| right adrenal gland cortex | UBERON:0035827 | 81.93 | gold quality |
| right lobe of thyroid gland | UBERON:0001119 | 81.88 | gold quality |
| right adrenal gland | UBERON:0001233 | 81.87 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 81.75 | gold quality |
| primordial germ cell in gonad | CL:0000670 ∩ UBERON:0000991 | 81.74 | gold quality |
| body of stomach | UBERON:0001161 | 81.69 | gold quality |
| metanephros cortex | UBERON:0010533 | 81.67 | gold quality |
| cerebellar hemisphere | UBERON:0002245 | 81.59 | gold quality |
| cerebellar cortex | UBERON:0002129 | 81.56 | gold quality |
| skin of abdomen | UBERON:0001416 | 81.54 | gold quality |
| minor salivary gland | UBERON:0001830 | 81.54 | gold quality |
| ovary | UBERON:0000992 | 81.48 | gold quality |
| cerebellum | UBERON:0002037 | 81.44 | gold quality |
| left adrenal gland cortex | UBERON:0035825 | 81.40 | gold quality |
Single-cell (SCXA)
Detected in 2 experiment(s), a significant marker in 0.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-MTAB-6075 | no | 328.25 |
| E-ANND-3 | no | 1.08 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
24 targeting AGAP5, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4682 | 100.00 | 68.89 | 1258 |
| HSA-MIR-548C-3P | 99.99 | 74.01 | 7587 |
| HSA-MIR-607 | 99.97 | 73.62 | 5593 |
| HSA-MIR-507 | 99.97 | 70.11 | 1915 |
| HSA-MIR-557 | 99.96 | 70.01 | 1640 |
| HSA-MIR-3671 | 99.90 | 73.04 | 3897 |
| HSA-MIR-5010-3P | 99.83 | 70.60 | 2357 |
| HSA-MIR-8080 | 99.82 | 67.52 | 1342 |
| HSA-MIR-4799-5P | 99.82 | 70.60 | 2663 |
| HSA-MIR-448 | 99.79 | 72.37 | 2103 |
| HSA-MIR-4428 | 99.73 | 66.41 | 1733 |
| HSA-MIR-10393-3P | 99.72 | 66.56 | 961 |
| HSA-MIR-6801-5P | 99.72 | 66.50 | 981 |
| HSA-MIR-4699-3P | 99.71 | 70.15 | 3142 |
| HSA-MIR-5700 | 99.64 | 69.88 | 2280 |
| HSA-MIR-377-3P | 99.37 | 70.18 | 1905 |
| HSA-MIR-223-5P | 99.24 | 68.82 | 1206 |
| HSA-MIR-1278 | 97.75 | 67.55 | 628 |
| HSA-MIR-873-3P | 96.84 | 66.09 | 786 |
| HSA-MIR-212-5P | 96.83 | 67.43 | 950 |
| HSA-MIR-635 | 96.00 | 65.54 | 687 |
| HSA-MIR-6774-5P | 95.94 | 65.18 | 722 |
| HSA-MIR-2861 | 95.24 | 65.47 | 1056 |
| HSA-MIR-4661-5P | 93.34 | 67.13 | 400 |
Functional genomics
DepMap (CRISPR cell-line fitness): dependent in 80.6% of screened cell lines.
Cross-species orthologs
0 orthologs
Paralogs (28): ARAP2 (ENSG00000047365), ACAP1 (ENSG00000072818), SMAP2 (ENSG00000084070), ASAP3 (ENSG00000088280), ARFGAP1 (ENSG00000101199), ADAP1 (ENSG00000105963), AGFG2 (ENSG00000106351), GIT1 (ENSG00000108262), SMAP1 (ENSG00000112305), ACAP2 (ENSG00000114331), ARAP3 (ENSG00000120318), ACAP3 (ENSG00000131584), AGAP3 (ENSG00000133612), AGAP2 (ENSG00000135439), APPL2 (ENSG00000136044), GIT2 (ENSG00000139436), ARFGAP2 (ENSG00000149182), ASAP2 (ENSG00000151693), ASAP1 (ENSG00000153317), APPL1 (ENSG00000157500), AGAP1 (ENSG00000157985), AGFG1 (ENSG00000173744), ADAP2 (ENSG00000184060), ARAP1 (ENSG00000186635), AGAP4 (ENSG00000188234), AGAP6 (ENSG00000204149), AGAP9 (ENSG00000204172), ARFGAP3 (ENSG00000242247)
Protein
Protein identifiers
Arf-GAP with GTPase, ANK repeat and PH domain-containing protein 5 — A6NIR3 (reviewed: A6NIR3)
Alternative names: Centaurin-gamma-like family member 2
All UniProt accessions (3): A6NIR3, J3KQL4, U3KQ60
UniProt curated annotations — full annotation on UniProt →
Function. Putative GTPase-activating protein.
Miscellaneous. Encoded by one of the numerous copies of centaurin gamma-like genes clustered in the q11 region of chromosome 10.
Similarity. Belongs to the centaurin gamma-like family.
RefSeq proteins (1): NP_001137472* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001164 | ArfGAP_dom | Domain |
| IPR001849 | PH_domain | Domain |
| IPR002110 | Ankyrin_rpt | Repeat |
| IPR011993 | PH-like_dom_sf | Homologous_superfamily |
| IPR036770 | Ankyrin_rpt-contain_sf | Homologous_superfamily |
| IPR037278 | ARFGAP/RecO | Homologous_superfamily |
| IPR038508 | ArfGAP_dom_sf | Homologous_superfamily |
| IPR051282 | Arf-GAP_GTPase_ANK_PH | Family |
Pfam: PF01412, PF12796
UniProt features (15 total): compositionally biased region 3, sequence conflict 3, region of interest 3, domain 2, repeat 2, chain 1, zinc finger region 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-A6NIR3-F1 | 62.80 | 0.38 |
Function
Pathways and Gene Ontology
Reactome pathways
0 pathways
MSigDB gene sets: 18 (showing top):
GOMF_GTPASE_ACTIVITY, GOMF_HYDROLASE_ACTIVITY_ACTING_ON_ACID_ANHYDRIDES, GOMF_ENZYME_ACTIVATOR_ACTIVITY, GOMF_NUCLEOSIDE_TRIPHOSPHATASE_REGULATOR_ACTIVITY, GOMF_ENZYME_REGULATOR_ACTIVITY, ZNF8_TARGET_GENES, MIR607, MIR5010_3P, MIR377_3P, MIR6801_5P, MIR10393_3P, DESCARTES_FETAL_SPLEEN_AFP_ALB_POSITIVE_CELLS, ZNF697_TARGET_GENES, ZNF426_TARGET_GENES, GOMF_MOLECULAR_FUNCTION_ACTIVATOR_ACTIVITY
GO Biological Process (0):
GO Molecular Function (5): GTPase activity (GO:0003924), GTPase activator activity (GO:0005096), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (0):
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| ribonucleoside triphosphate phosphatase activity | 1 |
| GTPase activity | 1 |
| enzyme activator activity | 1 |
| GTPase regulator activity | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
Protein interactions and networks
STRING
172 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| AGAP5 | FAM241A | Q8N8J7 | 521 |
| AGAP5 | HDHD3 | Q9BSH5 | 475 |
| AGAP5 | MYOZ1 | Q9NP98 | 418 |
| AGAP5 | ZPLD1 | Q8TCW7 | 417 |
| AGAP5 | TLL2 | Q9Y6L7 | 401 |
| AGAP5 | Q05D86 | Q05D86 | 400 |
| AGAP5 | PLEKHS1 | Q5SXH7 | 396 |
| AGAP5 | KIF27 | Q86VH2 | 393 |
| AGAP5 | SYNPO2L | Q9H987 | 374 |
| AGAP5 | POFUT4 | Q495W5 | 358 |
| AGAP5 | KDELR3 | O43731 | 355 |
| AGAP5 | WDR74 | Q6RFH5 | 351 |
| AGAP5 | PLCL2 | Q9UPR0 | 350 |
| AGAP5 | ANKRD53 | Q8N9V6 | 348 |
| AGAP5 | GTF2H2C | Q6P1K8 | 348 |
IntAct
3 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| AGAP5 | HSPB1 | psi-mi:“MI:0915”(physical association) | 0.370 |
| NEK4 | E2F8 | psi-mi:“MI:0914”(association) | 0.350 |
BioGRID (5): AGAP5 (Two-hybrid), AGAP5 (Affinity Capture-MS), AGAP5 (Affinity Capture-MS), AGAP5 (Negative Genetic), AGAP5 (Negative Genetic)
ESM2 similar proteins: A0A1L8F1M4, A0A8M9QN10, A0JMQ9, A6NIR3, A8DZE6, A8WH69, B2KF05, F1QCY8, O43147, O43900, O54880, P0C6P5, P59729, P97433, Q13009, Q18PD9, Q2NKQ1, Q32L09, Q3U5C7, Q58D79, Q5EB20, Q5PQS0, Q5U464, Q60592, Q6IVY4, Q6P0Q8, Q6ZQF7, Q6ZUJ8, Q71QF9, Q768S4, Q7T2V3, Q7TNN8, Q7TSI1, Q7ZVP1, Q803A0, Q80U12, Q80VL3, Q80Y24, Q8BPQ7, Q8BRB7
Diamond homologs: A0A8V8TMC4, A6NIR3, D3YUJ3, P0C7X3, P34624, Q08CI4, Q28EL0, Q4R871, Q5T2Q4, Q5U5D0, Q5VUJ5, Q5VW22, Q6NRF4, Q8BGU5, Q8N7R7, Q8ND76, Q96P64, A1L520, A1Z7A6, A5PK26, O43150, O74345, O75689, O80925, O82171, O94601, O97902, P35197, P38682, P40529, P52594, Q04412, Q09531, Q0WQQ1, Q10165, Q10367, Q14161, Q15027, Q15057, Q17R07
SIGNOR signaling
0 interactions.
Disease & clinical
Clinical variants and AI predictions
ClinVar
127 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 119 |
| Likely benign | 2 |
| Benign | 2 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
927 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 10:73676769:CT:C | acceptor_gain | 1.0000 |
| 10:73676771:C:CC | acceptor_gain | 1.0000 |
| 10:73680067:TCAC:T | donor_loss | 1.0000 |
| 10:73680068:CACCT:C | donor_loss | 1.0000 |
| 10:73680069:A:C | donor_loss | 1.0000 |
| 10:73680070:C:CG | donor_loss | 1.0000 |
| 10:73680103:CACA:C | acceptor_gain | 1.0000 |
| 10:73680105:CA:C | acceptor_gain | 1.0000 |
| 10:73680107:C:CC | acceptor_gain | 1.0000 |
| 10:73682692:A:AC | donor_gain | 1.0000 |
| 10:73682693:C:CC | donor_gain | 1.0000 |
| 10:73682793:ACC:A | acceptor_loss | 1.0000 |
| 10:73682794:CCT:C | acceptor_loss | 1.0000 |
| 10:73682796:T:A | acceptor_loss | 1.0000 |
| 10:73692078:C:CC | acceptor_gain | 1.0000 |
| 10:73694735:CCAT:C | donor_gain | 1.0000 |
| 10:73694803:AG:A | acceptor_gain | 1.0000 |
| 10:73694803:AGC:A | acceptor_loss | 1.0000 |
| 10:73694804:GCTA:G | acceptor_loss | 1.0000 |
| 10:73694805:C:CC | acceptor_gain | 1.0000 |
| 10:73694805:C:T | acceptor_loss | 1.0000 |
| 10:73694809:A:AC | acceptor_gain | 1.0000 |
| 10:73694809:A:C | acceptor_gain | 1.0000 |
| 10:73694812:CA:C | acceptor_gain | 1.0000 |
| 10:73694813:A:AC | acceptor_gain | 1.0000 |
| 10:73694813:A:C | acceptor_gain | 1.0000 |
| 10:73697528:CTTA:C | donor_loss | 1.0000 |
| 10:73697529:TTACC:T | donor_loss | 1.0000 |
| 10:73697530:TA:T | donor_loss | 1.0000 |
| 10:73697531:ACCT:A | donor_loss | 1.0000 |
AlphaMissense
4546 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 10:73675391:A:C | F423L | 0.957 |
| 10:73675391:A:T | F423L | 0.957 |
| 10:73675393:A:G | F423L | 0.957 |
| 10:73675746:A:T | V305D | 0.936 |
| 10:73674669:G:T | A664D | 0.925 |
| 10:73674932:A:C | F576L | 0.914 |
| 10:73674932:A:T | F576L | 0.914 |
| 10:73674934:A:G | F576L | 0.914 |
| 10:73675427:A:C | F411L | 0.914 |
| 10:73675427:A:T | F411L | 0.914 |
| 10:73675429:A:G | F411L | 0.914 |
| 10:73675787:C:A | K291N | 0.913 |
| 10:73675787:C:G | K291N | 0.913 |
| 10:73674766:A:G | C632R | 0.912 |
| 10:73675360:A:G | W434R | 0.912 |
| 10:73675360:A:T | W434R | 0.912 |
| 10:73674777:A:T | L628H | 0.903 |
| 10:73675805:T:A | K285N | 0.903 |
| 10:73675805:T:G | K285N | 0.903 |
| 10:73675392:A:G | F423S | 0.900 |
| 10:73675358:C:A | W434C | 0.894 |
| 10:73675358:C:G | W434C | 0.894 |
| 10:73675399:A:G | W421R | 0.883 |
| 10:73675399:A:T | W421R | 0.883 |
| 10:73674764:G:C | C632W | 0.881 |
| 10:73674950:T:A | K570N | 0.868 |
| 10:73674950:T:G | K570N | 0.868 |
| 10:73675428:A:G | F411S | 0.860 |
| 10:73674670:C:G | A664P | 0.844 |
| 10:73674681:G:T | A660E | 0.837 |
dbSNP variants (sampled 300 via entrez): RS1000104499 (10:73699673 C>T), RS1000346048 (10:73688046 TCTAA>T), RS1000570137 (10:73678366 T>C), RS1000581646 (10:73677788 T>G), RS1000837625 (10:73687778 C>T), RS1001004661 (10:73687204 C>A), RS1001187063 (10:73688444 T>G), RS1001279906 (10:73695076 A>T), RS1001289589 (10:73694573 A>C,G), RS1001341932 (10:73694134 A>C), RS1001782497 (10:73676649 G>A,T), RS1002009993 (10:73679877 A>G), RS1002117938 (10:73679388 T>C,G), RS1002946712 (10:73689144 G>A), RS1003015082 (10:73696692 C>A)
Disease associations
OMIM: gene MIM:621156 | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
6 associations (top):
| Study | Trait | p-value |
|---|---|---|
| GCST005023_14 | Initial pursuit acceleration | 9.000000e-06 |
| GCST006414_1 | Atrial fibrillation | 9.000000e-35 |
| GCST007267_52 | Systolic blood pressure | 4.000000e-13 |
| GCST007269_188 | Pulse pressure | 2.000000e-09 |
| GCST007656_13 | Chronic obstructive pulmonary disease or resting heart rate (pleiotropy) | 2.000000e-10 |
| GCST009541_9 | Heart failure | 1.000000e-09 |
EFO canonical traits (3, from GWAS)
| EFO ID | Trait name |
|---|---|
| EFO:0008434 | initial pursuit acceleration |
| EFO:0006335 | systolic blood pressure |
| EFO:0005763 | pulse pressure measurement |
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
3 total (human), top 3 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| Cadmium | decreases expression, increases abundance | 2 |
| Cadmium Chloride | decreases expression, increases abundance | 1 |
| Acrylamide | increases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
- Disease cohort memberships (association, not causation — diseases whose associated-gene cohort lists this gene; a subset are also under Associated diseases): heart failure